Literature DB >> 15556623

The intravenous anesthetic propofol inhibits hypoxia-inducible factor 1 activity in an oxygen tension-dependent manner.

Satoshi Takabuchi1, Kiichi Hirota, Kenichiro Nishi, Seiko Oda, Tomoyuki Oda, Koh Shingu, Arimichi Takabayashi, Takehiko Adachi, Gregg L Semenza, Kazuhiko Fukuda.   

Abstract

Hypoxia elicits a wide range of responses that occur at different organizational levels in the body. Hypoxia is not only a signal for energy conservation and metabolic change, but triggers expression of a select set of genes. The transcription factor hypoxia-inducible factor 1 (HIF-1) is now appreciated to be a master factor of the gene induction. Although knowledge on molecular mechanisms of HIF-1 activation in response to hypoxia is accumulating, the molecular mechanism of maintenance of HIF-1 activity under normoxic conditions remains to be elucidated. We demonstrate that the intravenous anesthetic propofol reversibly inhibits HIF-1 activity and the gene expression mediated by HIF-1 by blocking the synthesis of the HIF-1alpha subunit under 20% or 5% O2 conditions, but not under 1% O2 conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15556623     DOI: 10.1016/j.febslet.2004.10.042

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Effect of propofol post-treatment on blood-brain barrier integrity and cerebral edema after transient cerebral ischemia in rats.

Authors:  Jae Hoon Lee; Hui Song Cui; Seo Kyung Shin; Jeong Min Kim; So Yeon Kim; Jong Eun Lee; Bon-Nyeo Koo
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

2.  Opioid receptor stimulation does not affect cellular hypoxia-induced gene responses mediated by hypoxia-inducible factor 1 in cultured cell lines.

Authors:  Satoshi Takabuchi; Kiichi Hirota; Seiko Oda; Kenichiro Nishi; Tomoyuki Oda; Koh Shingu; Takehiko Adachi; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

Review 3.  Role of Endothelial Prolyl-4-Hydroxylase Domain Protein/Hypoxia-Inducible Factor Axis in Acute Kidney Injury.

Authors:  Ratnakar Tiwari; Pinelopi P Kapitsinou
Journal:  Nephron       Date:  2021-09-01       Impact factor: 3.457

4.  Propofol regulates miR-1-3p/IGF1 axis to inhibit the proliferation and accelerates apoptosis of colorectal cancer cells.

Authors:  Ling-Ling Ye; Zhong-Gui Cheng; Xiao-E Cheng; Yuan-Lu Huang
Journal:  Toxicol Res (Camb)       Date:  2021-06-14       Impact factor: 2.680

Review 5.  Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer.

Authors:  Xiu Chen; Peng Lu; Lin Chen; Su-jin Yang; Hong-Yu Shen; Dan-dan Yu; Xiao-hui Zhang; Shan-liang Zhong; Jian-hua Zhao; Jin-hai Tang
Journal:  Tumour Biol       Date:  2015-09-17

6.  The intravenous anesthetic propofol inhibits lipopolysaccharide-induced hypoxia-inducible factor 1 activation and suppresses the glucose metabolism in macrophages.

Authors:  Tomoharu Tanaka; Satoshi Takabuchi; Kenichiro Nishi; Seiko Oda; Takuhiko Wakamatsu; Hiroki Daijo; Kazuhiko Fukuda; Kiichi Hirota
Journal:  J Anesth       Date:  2009-12-29       Impact factor: 2.078

Review 7.  Hypoxia-dependent signaling in perioperative and critical care medicine.

Authors:  Kiichi Hirota
Journal:  J Anesth       Date:  2021-05-18       Impact factor: 2.078

8.  General anesthetics inhibit erythropoietin induction under hypoxic conditions in the mouse brain.

Authors:  Tomoharu Tanaka; Shinichi Kai; Tomohiro Koyama; Hiroki Daijo; Takehiko Adachi; Kazuhiko Fukuda; Kiichi Hirota
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

Review 9.  Involvement of hypoxia-inducible factors in the dysregulation of oxygen homeostasis in sepsis.

Authors:  Kiichi Hirota
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2015

10.  Differential roles of prostaglandin E-type receptors in activation of hypoxia-inducible factor 1 by prostaglandin E1 in vascular-derived cells under non-hypoxic conditions.

Authors:  Kengo Suzuki; Kenichiro Nishi; Satoshi Takabuchi; Shinichi Kai; Tomonori Matsuyama; Shin Kurosawa; Takehiko Adachi; Takayuki Maruyama; Kazuhiko Fukuda; Kiichi Hirota
Journal:  PeerJ       Date:  2013-11-28       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.